LongevitymTOR inhibition Phase 3 clinical trial fails.

User avatar
AlbertY
Posts: 152
Joined: Mon Aug 12, 2019 4:01 pm
Location: Boston, MA

mTOR inhibition Phase 3 clinical trial fails.

Post by AlbertY » Sun Nov 24, 2019 11:34 am

resTORbio Announces That the Phase 3 PROTECTOR 1 Trial of RTB101 in Clinically Symptomatic Respiratory Illness Did Not Meet the Primary Endpoint

RTB101 were inhibiting mTORC1, to minimize side effects of whole TOR inhibition, and targeting respiratory illness.

https://ir.restorbio.com/news-releases/ ... linically/


Ph.D. student at Harvard Medical School, doing research on aging
Drdavid
Posts: 701
Joined: Thu Aug 15, 2019 9:59 am

Re: mTOR inhibition Phase 3 clinical trial fails.

Post by Drdavid » Sun Nov 24, 2019 12:50 pm

This is disappointing but I hope some of the other research regarding mTor inhibition will provide satisfying results especially in the Parkinson diagnosis catagory.
Thank you for sharing this research
canadahealthy
Posts: 192
Joined: Tue Aug 20, 2019 5:31 pm

Re: mTOR inhibition Phase 3 clinical trial fails.

Post by canadahealthy » Sun Nov 24, 2019 3:30 pm

Failure is disappointing, but the scientific method is paving the way for accurate, successful treatments.

This is patently obvious to many people here, but some times anecdotal evidence is not evidence at all - it needs the trials.
Post Reply Previous topicNext topic